0001013606-19-000169.txt : 20191001 0001013606-19-000169.hdr.sgml : 20191001 20191001163031 ACCESSION NUMBER: 0001013606-19-000169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190927 FILED AS OF DATE: 20191001 DATE AS OF CHANGE: 20191001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thompson Matthew CENTRAL INDEX KEY: 0001740988 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 191129473 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495984741 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 4 1 wf-form4_156996180819122.xml FORM 4 X0306 4 2019-09-27 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0001740988 Thompson Matthew 2 MUSICK IRVINE CA 92618 0 1 0 0 Chief Medical Officer Option to Purchase 48.2 2019-09-27 4 D 0 8999 D 2017-06-30 2027-05-31 Common Stock 8999.0 0 D Option to Purchase 69.1 2019-09-27 4 D 0 9907 D 2017-12-01 2026-12-01 Common Stock 9907.0 0 D Option to Purchase 4.71 2019-09-27 4 A 0 6304 A 2020-09-10 2026-09-10 Common Stock 6304.0 6304 D Options vest ratably over forty-eight months. The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 8,999 shares of common stock granted to the reporting person on May 31, 2017, and (ii) an option for 9,907 shares of common stock granted to the reporting person on December 1, 2016. In exchange, the reporting person received a new stock option, for 6,304 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019. Twenty-five percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter. The options vest in three equal annual installments over a three-year period commencing on September 10, 2019. Matthew Thompson by Timothy N. Brady Attorney-in-Fact for Reporting Person 2019-10-01